↓ Skip to main content

CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine

Overview of attention for article published in Frontiers in immunology, July 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
89 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine
Published in
Frontiers in immunology, July 2019
DOI 10.3389/fimmu.2019.01806
Pubmed ID
Authors

Roberto S. Accolla, Elise Ramia, Alessandra Tedeschi, Greta Forlani

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 89 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 20%
Student > Ph. D. Student 11 12%
Student > Bachelor 11 12%
Student > Master 8 9%
Other 4 4%
Other 6 7%
Unknown 31 35%
Readers by discipline Count As %
Immunology and Microbiology 20 22%
Biochemistry, Genetics and Molecular Biology 14 16%
Medicine and Dentistry 5 6%
Agricultural and Biological Sciences 3 3%
Computer Science 2 2%
Other 9 10%
Unknown 36 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 October 2020.
All research outputs
#7,783,733
of 25,385,509 outputs
Outputs from Frontiers in immunology
#9,050
of 31,539 outputs
Outputs of similar age
#129,767
of 359,103 outputs
Outputs of similar age from Frontiers in immunology
#298
of 702 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 31,539 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,103 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 702 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.